Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06048887 · ClinicalTrials.gov registry record · Phase 1
Single and Multiple-Ascending Dose Study of CRN04894 in Healthy Volunteers
A Phase 1 study, sponsored by Crinetics Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 88
- Enrollment target
NCT06048887: Completed Phase 1 study, sponsored by Crinetics Pharmaceuticals.
NCT06048887 is a Phase 1 study that has completed, run by Crinetics Pharmaceuticals. The registered enrollment target is 88 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06048887, a Phase 1 study, has completed, sponsored by Crinetics Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 88 participants
- Enrollment target
Study Summary
A Phase 1, first-in-human, double-blind, randomized, placebo-controlled study to evaluate the safety of CRN04894 in healthy volunteers as well as the relationship between exposure and pharmacodynamic (PD) parameters.
Interventions
- DRUG Placebo Oral Solution
- DRUG CRN04894 Oral Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2020-12-18 |
| Est. Completion | 2022-04-11 |
| Phase | Phase 1 |
What the finished NCT06048887 record still lists
NCT06048887 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo Oral Solution is the first listed.
NCT06048887 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06048887 about?
NCT06048887 is a clinical study titled "Single and Multiple-Ascending Dose Study of CRN04894 in Healthy Volunteers". A Phase 1, first-in-human, double-blind, randomized, placebo-controlled study to evaluate the safety of CRN04894 in healthy volunteers as well as the relationship between exposure and pharmacodynamic (PD) parameters.
What is the current status of trial NCT06048887?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 88 participants. The study started on 2020-12-18. Estimated completion is 2022-04-11.
What interventions are being tested in trial NCT06048887?
The interventions under investigation include: Placebo Oral Solution (DRUG), CRN04894 Oral Solution (DRUG).
Who is sponsoring clinical trial NCT06048887?
This trial is sponsored by Crinetics Pharmaceuticals, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06048887's enrollment target sits among peer trials
88 650th of 2000 higher than 1,350 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI